MATTERHORN trial finds TEER non-inferior to surgery for secondary mitral regurgitation

TEER and surgery showed no difference in efficacy for secondary mitral regurgitation (MR) in the MATTERHORN trial, with non-inferiority confirmed. Both methods effectively improved MR, though TEER had safety benefits, with fewer major complications.